Skip to main content
SpringerLink
Log in

Influence of calcitonin treatment on the osteocalcin concentration in the algodystrophy of bone

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Algodystrophy (AD) attacks all tissues in the affected region and results in the rapid demineralization of bones. Osteocalcin (OC) and alkaline phosphatase (AP) are markers of bone turnover. Calcitonin is the treatment of choice of AD. Two groups of patients were studied: Group I (n=8)-acute stage of AD (before and during the calcitonin treatment), Group II (n=5)-late chronic stage of AD. In the acute stage of AD both OC level and AP activity were increased. They were normal in the chronic state of AD. During the calcitonin treatment OC level normalized after 14 days and then increased again. During the treatment, AP activity temporarily increased and then returned to the initial level. We confirm that an increased bone turnover is observed in the acute stage of AD. Discrepancy between OC level and AP activity reflects the local metabolic disturbances. Salmon calcitonin inhibits the algodystrophic process and probably contributes to the activation of the skeletal restoration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Doury, P. Algodystrophy. Reflex sympathetic dystrophy syndrome. Clin Rheumatol, 1987, 7, 173–80.

    Article  Google Scholar 

  2. Carlson, T., Jacobs, A.M. Reflex sympathetic dystrophy syndrome. J Foot Surg 1986, 25, 149–153.

    CAS  PubMed  Google Scholar 

  3. Doury, P., Pattin, S., Eulry, F., Faquert, P., Granier, R., Graillard, J.F. L'algodystropiie du genou. A propos d'une série de 125 observations. Rev Rhum Mal Osteoartic 1987, 54, 655–659.

    CAS  PubMed  Google Scholar 

  4. Reginster, J.Y., Gritten, C., Franchimont, P. L'olgodystrophie. Rev Méd Liège 1986, 41, 996–1003.

    CAS  PubMed  Google Scholar 

  5. Renier, J.C., Basle, M., Arlet, J., Seret, P. L'os et le métabolisme phosphocalcique dans l'algodystrophie. Rev Rhum Mal Osteoartic 1983, 50, 23–31.

    CAS  PubMed  Google Scholar 

  6. DeGuembecker, W., DeGuembecker, C., Duriez, R., Duriez, J. Apport de l'absorption photonique dans le diagnostic des algodystrophis décalcifiantes des pieds. Rev Rhum Mal Osteoartic 1982, 49, 887–890.

    CAS  Google Scholar 

  7. Krawzak, H.W., Lindecken, K.D., Beyer, H.K., Mayer, M. Quantifizierung von Mineralisationsprozessen bei posttraumatischer Algodystrophie mittels computerotomographischer Densitometrie. Z Orthop 1989, 127, 202–206.

    Article  CAS  PubMed  Google Scholar 

  8. Sarrat, P., Acquaviva, P.C., Laforgue, P., Zakarian, H., Lopez, M., Bouscarle, B. L'algodystrophie de la tête fémorale. Apport des nouvelles méthodes d'imagerie. J Radiol 1988, 69, 495–500.

    CAS  PubMed  Google Scholar 

  9. Constantinesco, A., Brunot, B., Demangeat, J.L., Foucher, G., Farcot, J.M. Apport de la scintigraphie osseuse en trois phases au diagnostic précoce de l'algodystrophie. Ann Chir Main 1986, 5, 93–104.

    Article  CAS  PubMed  Google Scholar 

  10. Rutishauser, E., Vernet, A., Marabraud, A. L'ostéoporose posttraumatique. Etude histopathologique.Acta Chir Belg 1956 (Suppl I) 123–148.

    Google Scholar 

  11. Rohner, A., Contribution à l'étude histopatologique de la dystrophie de Sudeck. Ann Anat Pathol 1958, 3, 477–511.

    CAS  Google Scholar 

  12. Arlet, J., Ficat, P., Durroux, R., Girou de Gercourt, R. Histopathologie des lésions osseuses et cartilagineuses dans l'algodystrophie sympathique réflexe du genou. Rev Rhum Mal Osteoartic 1981, 48, 315–321.

    CAS  PubMed  Google Scholar 

  13. Arlet, J., Ficat, P., Durroux, R., Theallier, J.P., Mazières, B., Bouteiller, G. Histopathologie des lésions osseuses dans 9 cas d'algodystrophie de la hanche. Rev Rheum Mal Osteoartic 1978, 45, 691–698.

    CAS  Google Scholar 

  14. Fournié, A., Demblans-Dechans, B., Fournié, B., Muller de la Caffinière, M.J. Algodystrophies et test à la calcitonine. Aperçus Physiopathologiques. Rev Rhum Mal Osteoartic 1982, 49, 879–882.

    PubMed  Google Scholar 

  15. Garcia-Carrasco, M., Gruson, M., De Vernejoul, M.C., Denne, M.A., Miravet, L. Osteocalcin and bone morphometric parameters in adults without bone disease. Calcif Tissue Int 1988, 42, 13–17.

    Article  CAS  PubMed  Google Scholar 

  16. Register, T.C., Wuthier, R.E. Effect of vanadate, a potent alkaline phosphatase inhibitor, on45Ca and32P uptake by a matrix vasicle-enriched fractions from chicken epiphyseal cartilage. J Biol Chem 1984, 259, 3511–3518.

    CAS  PubMed  Google Scholar 

  17. Chambers, T.J., Chambers, J.C., Symonds, J., Darby, J.A. The effect of human calcitonin on the cytoplasmic spreading of rat osteoclasts. J Clin Endocrinol Metab 1986, 63, 1080–1985.

    Article  CAS  PubMed  Google Scholar 

  18. Strettle, R.J., Bates, R.F.L., Buckley, G.A., Evidence for a direct anti-inflammatory action of calcitonin: inhibition of histamine-induced mouse pinnal oedema by porcine calcitonin. J Pharm Pharmacol 1980, 32, 192–195.

    Article  CAS  PubMed  Google Scholar 

  19. Ceserani, R. Calcitonin and prostaglandin system. Life Sci 1979, 25, 1851–1856.

    Article  CAS  PubMed  Google Scholar 

  20. Roth, A., Kolaric, K. Analgetic activity of calcitonin in patients with painful osteolytic metastases of breast cancer. Oncology 1986, 43, 283–287.

    Article  CAS  PubMed  Google Scholar 

  21. Nuti, R., Vattimo, A., Martini, G., Turchetti, V., Righi, G.A. Carbocalcitonin treatment in Sudeck's atrophy. Clin Orthop Rel Res 1987, 215, 217–222.

    Google Scholar 

  22. Breitenfelder, J. Zur Therapie des Sudecks-Syndroms. Therapiewoche 1979, 29, 6578–6587.

    Google Scholar 

  23. Baylink, D.J., Taylor, A.K., Johnston, P., Leuken, S., Linkhart, S.G. Update on osteocalcin assays. Calcif Tissue Int 1991, 49 (Suppl), A4, 13.

    Google Scholar 

  24. Riggs, B.L., Tsai, K-S, Mann, K.G. Effects of acute increases in bone matrix degradation on circulating levels of bone Gla protein. J Bone Miner Res 1986, 1, 539–542.

    Article  CAS  PubMed  Google Scholar 

  25. Einhorn, T.A., Vigorita, V.J., Aaron, A. Localization of Technetium-99m-methylene diphosphonate in bone using microautoradiography. J Orthop Res 1986, 4, 180–187.

    Article  CAS  PubMed  Google Scholar 

  26. Vattimo, A., Martini, G., Pisani, M. Bone uptake of99mTc-MDP in man: its relationship with local blood flow. J Nucl Med All Sci 1982, 26, 173–179.

    CAS  Google Scholar 

  27. Farley, J.R., Hall, S.L., Tarbaux, N.M. Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dosedependent manner, and increases mouse bone formation, alone and in combination with fluoride. Calcif Tissue Int 1989, 45, 214–221.

    Article  CAS  PubMed  Google Scholar 

  28. Griffiths, J., Black, J. Separation and identification of alkaline phosphatase isoenzymes and isoforms in serum of healthy persons by isoelectric focusing. Clin Chem 1987, 33, 2171–2177.

    CAS  PubMed  Google Scholar 

  29. Arlet, J., Ficat, P. Phlébographie transosseuse, pression intramédullaire et oxymétrie du sang osseux au cours des algodystrophies sympathiques réflexes. Rev Rhum Mal Osteoartic 1982, 49, 883–885.

    CAS  PubMed  Google Scholar 

  30. Asherl, R., Blümel, G. Zum Krankheitsbild der Sudeck'schen Dystrophie. Fortschr Med 1981, 99, 712–720.

    Google Scholar 

  31. Bassett, C.A.L., Herrmann, I. Influence of oxygen concentration and mechanical factors on differentiation of connective tissue in vitro. Nature 1961, 160, 460–461.

    Article  Google Scholar 

  32. Wimalawansa, S.J. Calcitonin: molecular biology, physiology, pathophysiology and its therapeutic uses. In: Bone regulatory factors. Editor: Pecile, A., de Bernard, B. 1990, pp. 121–60.

  33. Taoussanis, K. Erfahrungsberich über die Behandlung des Sudeck-Syndroms mit Calcitonin. Med Welt 1981, 32, 1375–1377.

    CAS  PubMed  Google Scholar 

  34. Renier, J.C., Moreau, R., Bernat, M., Basle, M., Jallet, P., Minier, J.F., Apport des explorations isotopiques dynamiques dans l'étude des algodystrophies. Rev Rhum Mal Osteoartic 1979, 46, 235–241.

    CAS  PubMed  Google Scholar 

  35. Caniggia, A., Nuti, R., Galli, M., Loré, F., Turchetti, V., Righi, G.A., Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis. Calcif Tissue Int 1986, 38, 328–332.

    Article  CAS  PubMed  Google Scholar 

  36. Pak, C.Y.C., Sakhaee, K., Gallagher, C., Parcel, C., Peterson, R., Zerwekh, J.E., Lemke, M., Britton, F., Hsu, M.-C., Adams, B. Attainment of therapeutic fluoride levels in serum without major side-effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis. J Bone Miner Res 1986, 1, 563–571.

    Article  CAS  PubMed  Google Scholar 

  37. Papapoulos, S.E., Frolich, M., Mudde, A.H., Harnick, H.I.J., vd Berg, H., Bijvoet, O.L.M. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment. J Clin Endocinol Metab 1987, 65, 89–94.

    Article  CAS  Google Scholar 

  38. Mizunashi, K., Furukawa, Y., Miura, R., Yumita, R., Yumita, S., Sohn, H.E. Yoshinaga, K. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism. J Clin Invest 1988, 82, 861–865.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Longstreth, P.L., Malinak, L.R. Hydroxyproline and transient osteoporosis. Ann Intern Med 1972, 76, 833.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mineral Metabolism and Bone Pathology Unit, Dept. Neuroendocrinology, Medical Center for Postgraduate Education, Orthopaedic Hosptial, Barska 16/22, 02315, Warsaw, Poland

    A. Sawicki

  2. Dept. Endocrinology, Medical Center for Postgraduate Education, Warsaw, Poland

    P. Szulc

  3. Orthopaedic Hospital, Warsaw, Poland

    T. Sobczyk, J. Goliszewski & R. Labuszewski

  4. Fondation Recherche en Hormonologie, Paris-Fresnes, France

    P. Garnier

Authors
  1. A. Sawicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Szulc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Sobczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Goliszewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Garnier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Labuszewski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sawicki, A., Szulc, P., Sobczyk, T. et al. Influence of calcitonin treatment on the osteocalcin concentration in the algodystrophy of bone. Clin Rheumatol 11, 346–350 (1992). https://doi.org/10.1007/BF02207191

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02207191

Key words

Search

Navigation